Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
Tibco Spotfire Releases Four Apps in Line with Pharma's Push to Integrate Research and Clinical Trials
While business in the research segment has been flat for Tibco Spotfire over the last year, the company's clinical trials business is up about 300 percent, a company official said.
New to GenomeWeb? Register quickly here.